Bausch Health Companies Inc. (BHC – Q1FY20) – Strong potential from newly launched products.

in , on July 28, 2020

Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (“Bausch Health”), announced the European launch of the company’s first Extended Depth of Focus intraocular lens (IOL), LuxSmart™, and a new monofocal IOL, LuxGood™. Both feature preloaded delivery systems and Pure Refractive Optics (PRO) Technology.

Executive Summary

Financial Statements

– Income Statement and Forecast
– Balance Sheet
– Cash Flow
– Q1FY20 – Results Overview
– Segment Performance
– Key Developments
– FY20 Guidance & Conclusion
– Conclusion
– GAAP to Non-GAAP Reconciliation

Historical Performance

– Key Ratios
– Profitability Ratios, Asset Turnover Ratio, Growth Ratio
– Per share Items and Key ratios
– Key Balance Sheet and Cash Flow Items
– P/E Band

Product Performance and Key Developments

– Ownership
– Competition
– Key Developments

Valuation and Consensus Performance

– Relative Valuation
– Analyst Recommendations

Market Price Performance

Crispidea Coverage

No of Pages : 45

Release Information

  • Released
    :

    July 28, 2020

  • Last Updated
    :

    July 28, 2020